Influence of a lipase inhibitor on gastric sensitivity and accommodation to an orally ingested meal

Authors:

Abstract
Summary: Background : Intraduodenal administration of lipids, through lipid digestion and release of cholecystokinin (CCK), induces viscero‐visceral reflexes that affect gastric tone and sensitivity. It is unclear whether the same mechanisms control gastric function after an orally ingested meal.Aim : To evaluate the effect of orlistat, a selective lipase inhibitor, on gastric response to an orally administered meal.Methods : Eighteen healthy volunteers participated in this study. They were treated for 5 days with orlistat (120 mg) or placebo t.d.s. in a double‐blind randomized crossover design. During treatment, all subjects underwent a gastric barostat study, measurement of plasma CCK levels and a satiety drinking test.Results : Although CCK plasma levels were significantly decreased, pre‐treatment with orlistat failed to affect gastric compliance (72 ± 6 mL/mm Hg and 64 ± 6 mL/mm Hg, NS), gastric sensitivity (discomfort threshold 12.2 ± 0.6 mm Hg vs. 10.9 ± 0.6 mm Hg above minimal distending pressure, NS) or gastric accommodation (172 ± 41 mL vs. 206 ± 49 mL, NS) to an orally ingested meal. Furthermore, orlistat pre‐treatment had no significant effect on the amount of calories ingested during a satiety drinking test (1329 ± 88 kcal vs. 1217 ± 115 kcal, NS).Conclusion : Administration of a lipase inhibitor does not affect gastric compliance, sensitivity to distension and accommodation to an orally ingested meal, and does not influence meal‐induced satiety.

This publication has 33 references indexed in Scilit: